3-4

Aristo started its operations in 1971 with a manufacturing plant at Aurangabad, marketing operations in Mumbai with a field force of just 30 personnel. Since then Aristo has come a long way... From a turnover of US $ 8500 in 1971 to US $ 64 million in year 2000. The last few years have seen us blazing new trails and setting new standards in the pharmaceutical industry. The company has a formidable position in the industry. Sound infrastructure and well-qualified human force have helped Aristo to accomplish this achievement.

A leading USFDA approved pharmaceutical company (one of the top-10 pharmaceutical companies in India with global outreach) based at Hyderabad, Telangana is looking for the following experienced personnel for our Formulations units.

Applications are invited for the recruitment of following position on contractual basis with consolidated pay under the DBT sponsored project entitled, “Chemical profiling of Joha and black rice of Assam for nutritional, nutraceutical parameters and aroma compounds” at Institute of Advanced Study in Science and Technology (IASST) Garchuk, Guwahati (Assam). Eligible and interested candidates can submit application.

Post : Scientist-C/Equivalent

Sava Healthcare Limited is part of Sava Group, which is esteemed 2003 & head quartered in Pune, India, is an integrated WHO-GMP certified manufacturer & Exporter of one of the widest range of therapeutic products from solid/liquid dosage forms. Having presence in around 30 countries across the globe with all relevant regulatory accreditation the company has unbiased focus on quality, efficacy & reliability of its products. With strong R&D and technical competence, the company has developed excellence in manufacturing superlative quality products at enviable economy. The global distribution network with various regional offices in UAE, Mauritius, Singapore, Uzbekistan, and Russia caters to the growing demands of the changing world. No wonder, SAVA Group has received numerous accolades from Govt. of India in the category of Export business SAVA Healthcare Limited has setup world class R&D Center in Pune for development of innovative formulations and NDDS.

Post : Executive / Officer - R&D ( Analytical Development )

HETERO, research based approved USFDA, TGA, EU, PMDA, KFDA and WHO global pharmaceutical company established in 1993, focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages.

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Manager-Distribution

Shilpa Medicare Ltd. SEZ-Formulation Unit, we are among the fastest growing oncology formulation pharmaceutical company, looking for dynamic young energetic, creative and talented mate candidates for formulation unit at Jadcherla near Hyderabad

Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
Merck was also the first Merck Group Company to go public in the year 1981.  The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.  Merck Specialities Pvt. Ltd., the wholly owned Indian subsidiary of Merck KGaA, was incorporated in 2005.

Post : Global Technical Project Manager

Piramal Enterprises Ltd. provides a world class integrated drug discovery services platform from our state-of-the-art research Centre in India. PDS's delivery model has a proven track record of providing a step change in the effectiveness of drug discovery for a range of global pharmaceuticals and biotechnology companies operating at the forefront of drug discovery. PDS understands that early and intensive evaluation of the molecules based on thorough communications and rapid decision-making will lead to a high throughput of successful drug-like compounds.

Post : Executive - Q.A